Show simple item record

dc.contributor.authorLiu, Michael A
dc.contributor.authorHshieh, Tammy
dc.contributor.authorCondron, Nolan
dc.contributor.authorWadleigh, Martha
dc.contributor.authorAbel, Gregory A
dc.contributor.authorDriver, Jane A
dc.date.accessioned2016-12-06T01:15:24Z
dc.date.available2016-12-06T01:15:24Z
dc.date.issued2016-08-23
dc.identifier.citationRelationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies 2016, 115 (7):858 British Journal of Canceren
dc.identifier.issn0007-0920
dc.identifier.issn1532-1827
dc.identifier.pmid27552440
dc.identifier.doi10.1038/bjc.2016.260
dc.identifier.urihttp://hdl.handle.net/10150/621515
dc.description.abstractBackground: Few studies have investigated the relationship between physician and patient-assessed performance status (PS) in blood cancers. Methods: Retrospective analysis among 1418 patients with haematologic malignancies seen at Dana-Farber Cancer Institute between 2007 and 2014. We analysed physician-patient agreement of Eastern Cooperative Oncology Group PS using weighted kappa-statistics and survival analysis. Results: Mean age was 58.6 years and average follow-up was 38 months. Agreement in PS was fair/moderate (weighted kappa = 0.41, 95% CI 0.37-0.44). Physicians assigned a better functional status (lower score) than patients (mean 0.60 vs 0.81), particularly when patients were young and the disease was aggressive. Both scores independently predicted survival, but physician scores were more accurate. Disagreements in score were associated with poorer survival when physicians rated PS better than patients, and were modified by age, sex and severity of disease. Conclusions: Physician-patient disagreements in PS score are common and have prognostic significance.
dc.description.sponsorshipMSTAR Program (American Federation for Aging Research/NIH) [T35AG038027-05]; National Institute on Aging [T32AG000158]; Hartford Center of Excellence Award; Mary P. Murphy Fund for Hematologic Malignancies Research; Veterans' Administration Merit Review Awarden
dc.language.isoenen
dc.publisherNATURE PUBLISHING GROUPen
dc.relation.urlhttp://www.nature.com/doifinder/10.1038/bjc.2016.260en
dc.rightsCopyright © 2016 Cancer Research UK. This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectmedical oncologyen
dc.subjecthaematologic malignanciesen
dc.subjectleukaemiaen
dc.subjectlymphomaen
dc.subjectperformance statusen
dc.subjectepidemiologyen
dc.titleRelationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignanciesen
dc.typeArticleen
dc.contributor.departmentUniv Arizona, Coll Meden
dc.identifier.journalBritish Journal of Canceren
dc.description.note12 Month Embargo.en
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en
dc.eprint.versionFinal published versionen
refterms.dateFOA2017-08-23T00:00:00Z
html.description.abstractBackground: Few studies have investigated the relationship between physician and patient-assessed performance status (PS) in blood cancers. Methods: Retrospective analysis among 1418 patients with haematologic malignancies seen at Dana-Farber Cancer Institute between 2007 and 2014. We analysed physician-patient agreement of Eastern Cooperative Oncology Group PS using weighted kappa-statistics and survival analysis. Results: Mean age was 58.6 years and average follow-up was 38 months. Agreement in PS was fair/moderate (weighted kappa = 0.41, 95% CI 0.37-0.44). Physicians assigned a better functional status (lower score) than patients (mean 0.60 vs 0.81), particularly when patients were young and the disease was aggressive. Both scores independently predicted survival, but physician scores were more accurate. Disagreements in score were associated with poorer survival when physicians rated PS better than patients, and were modified by age, sex and severity of disease. Conclusions: Physician-patient disagreements in PS score are common and have prognostic significance.


Files in this item

Thumbnail
Name:
bjc2016260a.pdf
Size:
107.1Kb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

Copyright © 2016 Cancer Research UK. This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License.
Except where otherwise noted, this item's license is described as Copyright © 2016 Cancer Research UK. This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License.